Medical Science Liaison-Oncology
Pubblicato il 09-09-2026 - IQVIA Italia in Udine
On behalf of our Client, an international biotech company focused on the development of innovative oncology therapies, IQVIA, a global leader in services for the pharmaceutical and biotechnology industries, is seeking a Medical Science Liaison, Oncology.
Possiede le competenze e l'esperienza giuste per questo ruolo? Continui a leggere per scoprirlo e invii la sua candidatura.
The Medical Science Liaison facilitates and develops the relationship with the medical/scientific community including physicians and medical centers, by communicating scientific and medical therapy area related information to investigators and institutions. They provide information on research developments, and new concepts in medical treatment. The Medical Science Liaison will also participate in close partnership with Site Management & Monitoring staff in the initiation, oversight, and follow-up of clinical studies. This is done in a strictly scientific, non-promotional manner, and in full compliance with applicable laws and regulations, guidelines, codes of conduct.
RESPONSIBILITIES
- Provide field-based medical support to Company's clinical research programs;
- Deliver credible presentations on scientific matters in the disease area of responsibility and about company pipeline to investigators in company-sponsored interventional research;
- Engage with clinical trial site investigators and staff to understand enrollment/screening barriers from a medical perspective and work with the site and client to find potential medical solutions.
Aiming to support clinical trial enrollment;
- Provide support to company clinical development and operations teams through site recommendations, initiation visits, facilitation of communication, and accrual support activities;
- In an accurate, fair and balanced manner, exchange scientific information with external parties;
- Report field intelligence to IQVIA/Client including competitive information, perspectives about compounds, and the treatment landscape